Q4 Sales Performance vs. Expectations
Consolidated Q4 sales decreased 3.3% year‑over‑year but were favorable to the company’s outlook and described as exceeding expectations.
Free Cash Flow and Balance Sheet Actions
Fiscal 2026 free cash flow was $132 million despite $72 million of incremental tariff cash outflows; the company used proceeds from the subsequent sale of a distribution facility (~$78 million) plus operational cash to pay down $112 million of debt in the quarter.
Inventory Control
Year‑end inventory was $456 million, largely flat YoY despite $34 million of incremental tariff costs in inventory; the company accelerated inventory productivity, reducing slower‑moving stock by nearly $50 million in Q4.
Strong Brand and International Performance
Olive & June delivered organic growth of 18% and contributed ~4.9 percentage points to total segment sales; International sales grew 5.4% driven by expanded distribution and new product innovation. Revlon and Braun also outperformed in key channels/regions.
Tariff Mitigation Progress
Gross unmitigated tariffs had a $51 million impact on gross profit for the year; through SKU prioritization, price, and supplier diversification the company reduced net operating income impact to < $30 million and reduced COGS exposure to China tariffs to ~30% by year‑end, targeting <20% by end of FY2027.
Supply Chain and Sourcing Improvements
Dual‑sourcing capacity increased to ~45% of annual product volume with a target of ~55% by FY2027; capital plan includes continued supply‑chain diversification and $28–$32 million of capex focused on product innovation and diversification.
Positive Innovation and Awards
Several successful product launches and recognitions: Revlon Versa Styler early demand exceeded expectations; Hydro Flask new sizes and soft coolers; OXO Rapid Brewer and Hydro Flask won industry awards; Beauty brands earned multiple Glamour 2026 Best of Beauty awards.
FY2027 Financial Outlook with Growth Targets
FY2027 guidance: net sales $1.751B–$1.822B; adjusted EBITDA $190M–$197M (implies +2.1% to +6.3% YoY); adjusted EPS $3.25–$3.75; free cash flow $85M–$100M; target net leverage ≈3.2x or lower by year‑end.